Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2026
|
| Subjects: | |
| Online Access: | https://onlinelibrary.wiley.com/doi/10.1002/oby.70204 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Table of Contents:
- Virtual Weight Management and Continuous Glucose Monitoring in Patients With Type 2 Diabetes: A Randomized Controlled Trial Peter T. Katzmarzyk Kimberly Drews Jamy D. Ard Tracey L. McLaughlin Melissa N. Harris Alexandra Lee Gary D. Foster Hyun Jung Lee Timothy C. Dunn Corby K. Martin Frank L. Greenway Michelle I. Cardel Obesity ABSTRACT Objective This study examined the effectiveness of behavioral weight management integrated with continuous glucose monitoring (CGM) among adults with overweight or obesity and type 2 diabetes. Methods This was a two‐arm, parallel, randomized clinical trial. Participants ( n = 151) were randomly assigned to intervention (INT; n = 75) or usual care (UC; N = 76). INT participants received a behavioral weight management program tailored for type 2 diabetes and CGM. UC participants received a session with a dietitian and educational materials. The primary outcome was 6‐month change in HbA1c%. Additional outcomes included changes in weight, waist circumference, blood pressure, CGM metrics, diabetes stress, and treatment satisfaction. Results INT reduced HbA1c% (−0.87%; 95% CI: −1.17%, −0.57%) more than UC (−0.41%; −0.72%, −0.10%) (difference: −0.46%; −0.89%, −0.03%; p = 0.037). INT had greater reductions in percent body weight compared to UC (difference: −3.2%; −4.9%, −1.5%; p < 0.001). Several CGM metrics improved significantly more in INT than UC, and INT had significantly greater improvements in diabetes treatment satisfaction and regimen‐related diabetes stress relative to UC. Conclusions Integrating CGM with a digital weight management program produced significantly greater improvements in HbA1c%, body weight, and other glucose metrics compared to UC among adults with overweight or obesity and type 2 diabetes. Trial Registration ClinicalTrials.gov identifier: NCT05935514 image 10.1002/oby.70204 http://onlinelibrary.wiley.com/termsAndConditions#vor